Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipocyte | 10 studies | 30% ± 14% | |
| fibroblast | 7 studies | 21% ± 6% | |
| epithelial cell | 7 studies | 28% ± 9% | |
| type I pneumocyte | 6 studies | 26% ± 8% | |
| myofibroblast cell | 5 studies | 18% ± 3% | |
| cardiac muscle cell | 5 studies | 28% ± 4% | |
| hepatocyte | 5 studies | 42% ± 13% | |
| astrocyte | 5 studies | 32% ± 9% | |
| hematopoietic precursor cell | 3 studies | 20% ± 3% | |
| connective tissue cell | 3 studies | 20% ± 4% | |
| extravillous trophoblast | 3 studies | 25% ± 6% | |
| muscle cell | 3 studies | 23% ± 2% | |
| GABAergic neuron | 3 studies | 34% ± 6% | |
| glutamatergic neuron | 3 studies | 34% ± 9% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 5% | |
| intestinal crypt stem cell | 3 studies | 22% ± 3% | |
| basal cell | 3 studies | 22% ± 2% | |
| endothelial cell | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 10509.90 | 226 / 226 | 100% | 99.19 | 404 / 406 |
| kidney | 100% | 3326.76 | 89 / 89 | 99% | 84.07 | 895 / 901 |
| ovary | 100% | 4694.61 | 180 / 180 | 99% | 51.15 | 425 / 430 |
| prostate | 100% | 4044.79 | 244 / 245 | 99% | 61.26 | 498 / 502 |
| pancreas | 100% | 7252.80 | 328 / 328 | 98% | 63.17 | 175 / 178 |
| breast | 100% | 6345.61 | 458 / 459 | 98% | 55.16 | 1098 / 1118 |
| esophagus | 100% | 3661.93 | 1440 / 1445 | 98% | 41.01 | 179 / 183 |
| intestine | 100% | 4699.52 | 966 / 966 | 97% | 48.09 | 511 / 527 |
| skin | 100% | 3919.73 | 1800 / 1809 | 97% | 71.59 | 459 / 472 |
| lung | 97% | 3619.42 | 563 / 578 | 99% | 57.66 | 1143 / 1155 |
| thymus | 96% | 2455.43 | 629 / 653 | 99% | 45.37 | 596 / 605 |
| brain | 95% | 2938.08 | 2506 / 2642 | 100% | 66.25 | 704 / 705 |
| bladder | 100% | 4266.57 | 21 / 21 | 93% | 50.92 | 471 / 504 |
| stomach | 98% | 2679.09 | 351 / 359 | 95% | 43.08 | 272 / 286 |
| uterus | 94% | 2250.04 | 160 / 170 | 98% | 58.23 | 449 / 459 |
| adrenal gland | 100% | 7642.76 | 258 / 258 | 89% | 34.61 | 205 / 230 |
| muscle | 100% | 56403.34 | 803 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 47.77 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.72 | 1 / 1 |
| adipose | 100% | 7323.11 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 4785.00 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 37.07 | 28 / 29 |
| heart | 95% | 11154.54 | 820 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 86% | 2997.03 | 802 / 929 | 0% | 0 | 0 / 0 |
| spleen | 83% | 1492.24 | 199 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 55% | 13.66 | 44 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0033499 | Biological process | galactose catabolic process via UDP-galactose |
| GO_0006094 | Biological process | gluconeogenesis |
| GO_0006096 | Biological process | glycolytic process |
| GO_0006006 | Biological process | glucose metabolic process |
| GO_1904724 | Cellular component | tertiary granule lumen |
| GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0004614 | Molecular function | phosphoglucomutase activity |
| GO_0000287 | Molecular function | magnesium ion binding |
| Gene name | PGM1 |
| Protein name | Phosphoglucomutase 1 (EC 5.4.2.2) Phosphoglucomutase-1 (EC 5.4.2.2) (Glucose phosphomutase 1) Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1) |
| Synonyms | |
| Description | FUNCTION: This enzyme participates in both the breakdown and synthesis of glucose. . FUNCTION: This enzyme participates in both the breakdown and synthesis of glucose. . |
| Accessions | ENST00000371083.4 [P36871-2] A0A3B3ITK7 ENST00000540265.5 [P36871-3] P36871 ENST00000650546.1 ENST00000371084.8 [P36871-1] Q9H1D2 |